HER3 expression is enhanced during progression of lung adenocarcinoma without EGFR mutation from stage 0 to IA1

BACKGROUND: Activating EGFR mutations, HER2, and HER3 are implicated in lung cancer; however, with the exception of EGFR gene amplification in lung adenocarcinoma harboring EGFR mutations, their involvement in disease progression during the early stages is poorly understood. In this paper, we focuse...

全面介紹

Na minha lista:
書目詳細資料
發表在:Thorac Cancer
Main Authors: Kumagai, Toru, Tomita, Yasuhiko, Nakatsuka, Shin‐ichi, Kimura, Madoka, Kunimasa, Kei, Inoue, Takako, Tamiya, Motohiro, Nishino, Kazumi, Susaki, Yoshiyuki, Kusu, Takashi, Tokunaga, Toshiteru, Okami, Jiro, Higashiyama, Masahiko, Imamura, Fumio
格式: Artigo
語言:Inglês
出版: John Wiley & Sons Australia, Ltd 2018
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5879050/
https://ncbi.nlm.nih.gov/pubmed/29473311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12609
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍